Goldman Sachs’s Akili Inc AKLI Stock Holding History

Goldman Sachs’s Portfolio AKLI Stock Details AKLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,045	Closed	-$23.3M	–	5905
2023 Q3	$23.3M	Buy	+12,045	New	+$12K	0.01%	1649

Other funds holding AKLI

SCG

Social Capital Group Menlo Park, California $5.16M AUM 66.85% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

CFM

Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

TPC

Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs's AKLI Position: Q4 2023 in Review

Goldman Sachs sold out of Akili Inc (AKLI) in Q4 2023, closing a stake of 12,045 shares — an estimated $23.3M sold.

Goldman Sachs first reported a position in AKLI in Q3 2023 and held it in 1 quarter. The position peaked at $23.3M in Q3 2023. 34 funds tracked by Wall St. Rank hold AKLI as of Q4 2023.

Goldman Sachs reported no remaining Akili Inc position as of Q4 2023 after selling out during the quarter.
Goldman Sachs sold 12,045 Akili Inc shares in Q4 2023, an estimated $23.3M.
Goldman Sachs first reported a position in Akili Inc in Q3 2023 and held it in 1 quarter.
Goldman Sachs's Akili Inc position peaked at $23.3M in Q3 2023.
34 funds tracked by Wall St. Rank held Akili Inc as of Q4 2023.

Based on Goldman Sachs's 13F filing for Q4 2023, filed 13 Feb 2024.